Clinical Trial Update: BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BB-101 for diabetic foot ulcers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• BB-101

Snippet

Sponsor: Blue Blood Biotech Corp. | Conditions: Diabetic Foot Ulcer | Phase 2 | Status: RECRUITING